Participants 108 145 6
patients with gastrointestinal cancer
Participants 417 454 6
patients with gastrointestinal cancer
Participants 747 817 8
512 patients with gastrointestinal cancer included in the TACTIC study
Participants 832 878 5
89.2 per cent of patients had a primary tumour
Participants 883 935 5
79.7 per cent underwent surgery with curative intent
Participants 937 988 5
243 patients received perioperative RBC transfusion
Participants 1118 1126 3
LD group
Participants 1152 1164 3
non-LD group
Participants 1435 1472 4
patients with gastrointestinal cancer
